Article

MLI appoints president, company changes name

Pleasanton, CA—MLI (formerly Massie Laboratories) has appointed Keith L. Mullowney as president, chief executive officer, and board chairman of the advanced diagnostic and data capture systems company.

Pleasanton, CA-MLI (formerly Massie Laboratories) has appointed Keith L. Mullowney as president, chief executive officer, and board chairman of the advanced diagnostic and data capture systems company.

The company, which specializes in systems for pediatric and adult eye healthcare, also has changed its name to Clarity Medical Systems Inc.

"Clarity speaks to the ability to see and understand with acuity and insight," Mullowney said. "This is an ideal name for the future of the company because it represents both what our technology is designed to do, as well as our vision for transforming the delivery of eye healthcare."

Before joining Clarity Medical Systems Inc., Mullowney co-founded Thermage, a medical device company specializing in the aesthetic market, and served as its president and chief executive officer before becoming its chairman. Mullowney succeeds Mike Napier, the executive vice president and interim chief executive officer.

Related Videos
Arun Gulani, MD: How the Gni instrument enhances precision and control in cataract surgery
EyeCon 2024: Peter J. McDonnell, MD, marvels on mentoring, modern technology, and ophthalmology’s future
EyeCon Co-chair Oluwatosin U. Smith, MD: Passion for Research and Education Drives Her Commitment to Ophthalmology
Dr. SriniVas Sadda Discusses Vision for ARVO as New President: Collaboration, Funding Challenges, and Impact of Annual Meetings
Highlights from the 18th Annual Controversies in Modern Eye Care Symposium: Arjan Hura, MD, on Refractive Surgery, Retina Care, and Record Attendance
ASCRS 2024: ViaLase Updates on Nonincisional Glaucoma Treatment Targeting Trabecular Meshwork
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
© 2024 MJH Life Sciences

All rights reserved.